The Amnion Foundation is non-profit organization with the mission to build a genetically diverse public cell bank that can provide an immunological match to the majority of the population. Amniotic stem cells, which can be sourced from the amniotic fluid or the placenta after a live, healthy birth, possess a unique blend of multipotency and lack of tumorigenicity. In an extension of the cord blood banking model, these cells may improve outcomes where long-term cell survival and functionality is important.
Recently, I had the honor of interview Dr. Todd McAllister, Executive Director at Amnion Foundation. In this interview, we discuss the foundation’s vision, research and clinical approach, scale-out strategy, and interest in joint partnerships. It is captivating to get an insider look at the Amnion Foundation, a niche player within the large cord blood and tissue banking market.